To improve reproducibility; look first to pipetting
With years of experience and expertise with pipettes, Gustavo Chavarria outlines pipetting factors and practices that lead to success and […]
Read the post
5 Reasons Gene Therapy Companies are Vital to the Future of Biopharma
Pharmaceutical companies have been developing therapies to treat or prevent disease since the end of the 19th century. Chemical compounds […]
Read the post
Getting to Know Dr. James Garner, CEO of Kazia Therapeutics
Photo courtesy of Kazia Therapeutics. BioSpace recently spoke with Dr. James Garner, CEO of Kazia Therapeutics, an oncology company that […]
Read the post
AGT CEO Jeff Galvin on the Future of the Gene and Cell Therapy Industry
The rapid growth of biopharma is causing a shift to a new paradigm for the drug development and delivery model. […]
Read the post
Relmada Therapeutics Developing REL-1017 to Treat Major Depression
Depression affects hundreds of millions of people worldwide. Relmada Therapeutics is working to develop a treatment for those with depression […]
Read the post
Kazia’s Business Model
The path from idea to market in the oncology sector is long and expensive. In the traditional model of drug […]
Read the post